SYRENasdaqPharmaceutical PreparationsFiscal year ends December 31
Spyre Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$84.72+4.82 (+6.03%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Spyre Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 5, 2026 | Oct 7, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 8, 2026 | Sep 8, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 25, 2026 | Aug 25, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 4, 2026 | Aug 4, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 4, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 15, 2026 | Jun 15, 2026 | SEC EDGAR |
| Current report | 8-K | May 29, 2026 | Jun 1, 2026 | SEC EDGAR |
| Current report | 8-K | May 27, 2026 | May 29, 2026 | SEC EDGAR |
| Current report | 8-K | May 5, 2026 | May 5, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 5, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 14, 2026 | Apr 16, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 13, 2026 | Apr 13, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 13, 2026 | Apr 13, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | May 27, 2026 | Apr 10, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 19, 2026 | Feb 19, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 19, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2025 | Nov 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 4, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 13, 2025 | Oct 15, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 14, 2025 | Oct 14, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2025 | Aug 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 5, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2025 | Jun 17, 2025 | SEC EDGAR |
| Current report | 8-K | May 29, 2025 | Jun 2, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 29, 2025 | Apr 14, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 28, 2025 | Mar 6, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2025 | Feb 27, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 18, 2024 | Nov 19, 2024 | SEC EDGAR |
| Quarterly report, amended | 10-Q/A | Sep 30, 2024 | Nov 18, 2024 | SEC EDGAR |
| Quarterly report, amended | 10-Q/A | Jun 30, 2024 | Nov 18, 2024 | SEC EDGAR |
| Quarterly report, amended | 10-Q/A | Mar 31, 2024 | Nov 18, 2024 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2023 | Nov 18, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 18, 2024 | Nov 18, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |